Forte Biosciences (FBRX) Non-Current Assets (2016 - 2026)

Forte Biosciences (FBRX) has 11 years of Non-Current Assets data on file, last reported at $2.1 million in Q1 2026.

• On a quarterly basis, Non-Current Assets rose 601.99% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $6.1 million, a 429.46% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 918.6% from the prior year.
• Non-Current Assets for Q1 2026 stood at $2.1 million, down from $2.2 million in the prior quarter.
• Over the last five years, Non-Current Assets for FBRX reached as high as $2.2 million in Q4 2025 and fell as low as $167000.0 in Q2 2025.
• Historically, Non-Current Assets has averaged $759647.1 across 5 years, with a median of $515000.0 in 2024.
• Across the five-year window, Non-Current Assets plunged 67.08% in 2024 and jumped 918.6% in 2025, its largest moves.
• Year by year, Non-Current Assets stood at $486000.0 in 2022, then soared by 34.36% to $653000.0 in 2023, then plunged by 67.08% to $215000.0 in 2024, then soared by 918.6% to $2.2 million in 2025, then declined by 3.52% to $2.1 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $2.1 million in Q1 2026, $2.2 million in Q4 2025, and $1.7 million in Q3 2025.